Tyler

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Grifols Therapeutics LLC2 trials

Running trials

• Enrolling by invitation

  Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

  NCT02796937· Phase 3· Grifols Therapeutics LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

  NCT01983241· Phase 3· Grifols Therapeutics LLC· Source